좌골 신경통 치료 시장 규모, 점유율, 성장 분석 : 유형별, 약제 클래스별, 유통경로별, 지역별 - 업계 예측(2026-2033년)

Global Sciatica Treatment Market size was valued at USD 764.86 Million in 2024 and is poised to grow from USD 796.22 Million in 2025 to USD 1098.1 Million by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The growing prevalence of sciatica, marked by pain radiating along the sciatic nerve from the lower back through the legs, reflects significant market trends in the treatment sector. Factors such as increased sedentary lifestyles, rising obesity rates, and an aging population are major contributors to this surge. Additionally, advancements in diagnostic technologies have improved sciatica identification, resulting in higher reported cases. Evidence indicates that around 40% of the population experiences sciatica symptoms during their lifetime, particularly in individuals in their 40s and 50s, with men being more frequently affected than women. These insights highlight a robust demand for effective treatment solutions and emphasize the need for industry players to address emerging challenges in managing this prevalent condition.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sciatica Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sciatica Treatment Market Segments Analysis

Global Sciatica Treatment Market is segmented by Type, Drug Class, Distribution Channel and region. Based on Type, the market is segmented into Acute, Chronic and Others. Based on Drug Class, the market is segmented into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Antidepressants and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies and Retail & Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sciatica Treatment Market

One of the key market drivers for the global sciatica treatment market is the increasing prevalence of sedentary lifestyles and related health issues in the population. As more individuals engage in prolonged sitting due to desk jobs, unhealthy habits, and a lack of physical activity, the incidence of sciatica and associated conditions rises. This trend is further exacerbated by the aging population, which experiences a higher likelihood of spinal issues. Consequently, there is a growing demand for effective treatments and therapies, including medications, physical rehabilitation, and minimally invasive surgeries, driving innovation and investment in the sciatica treatment sector.

Restraints in the Global Sciatica Treatment Market

One significant market restraint for the global sciatica treatment market is the variability in treatment efficacy and the challenge of creating standardized treatment protocols. Sciatica is often caused by various underlying conditions, leading to complexities in diagnosis and treatment approaches. This variability can result in inconsistent patient outcomes and dissatisfaction, which may deter individuals from seeking treatment. Additionally, the high cost of advanced treatment options, coupled with limited insurance coverage for certain therapies, can further restrict access to care. These factors collectively hinder market growth by limiting the willingness of patients to invest in potentially costly sciatica treatments.

Market Trends of the Global Sciatica Treatment Market

The Global Sciatica Treatment market is experiencing robust growth driven by significant advancements in diagnostic imaging technologies, particularly MRI and CT scans. These innovations greatly enhance the precision of identifying the underlying causes of sciatica, which facilitates quicker and more accurate diagnoses, leading to timely interventions. The emphasis on early diagnosis is pivotal in preventing the progression of sciatica into chronic conditions, thereby promoting better patient outcomes and reducing the risk of associated disabilities. With the rising incidence of sciatica fueling demand for effective treatments, the market is poised for continued expansion as healthcare professionals leverage advanced imaging to tailor interventions for improved efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Sciatica Treatment Market Size by Type & CAGR (2026-2033)

• Market Overview
• Acute
• Chronic
• Others

Global Sciatica Treatment Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Corticosteroids
• Antidepressants
• Others

Global Sciatica Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail & Online Pharmacies

Global Sciatica Treatment Market Size & CAGR (2026-2033)

• North America (Type, Drug Class, Distribution Channel)
  • US
  • Canada
• Europe (Type, Drug Class, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Drug Class, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Drug Class, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Drug Class, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorrento Therapeutics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alkem Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eliem Therapeutics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinfonia Biotherapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Laser Systems Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations